Timing | RR(95% CI) | p | |||
---|---|---|---|---|---|
New admissions (time±95% CI) | <12 hours | 12–24 hours | >24 hours | ||
High risk(1.3 days±0.7) | n=26 | n=29 | n=43 | ||
Mean Haemoglobin (g/L) | 73.7±8.8 | 85.2±8.4 | 88.3±7.3 | 0.04 | |
Transfusion | 24 (92.3%) | 17 (58.6%) | 25 (58.1%) | 0.01 | |
Rebleeding | 5 (19.2%) | 7 (24.1%) | 7 (16.3%) | 0.71 | |
Repeat Intervention* | 5 (19.2%) | 9 (31.0%) | 6 (14.0%) | 0.21 | |
30 Day Mortality | 4 (15.4%) | 5 (17.2%) | 8 (18.6%) | 0.94 | |
Low risk(1.1 days±0.3) | n=30 | n=44 | n=62 | ||
Mean Hb (g/L) | 103.0±11.2 | 104.6±9.2 | 112.3±7.3 | 0.25 | |
Transfusion | 15 (50.0%) | 17 (38.6%) | 13 (21.0%) | 0.01 | |
Rebleeding | 5 (16.7%) | 4 (9.1%) | 7 (11.3%) | 0.60 | |
Repeat Intervention* | 5 (16.7%) | 4 (9.1%) | 5 (8.1%) | 0.42 | |
30 Day Mortality | 0 | 3 (6.8%) | 0 | NA | |
Inpatients (time±95% CI) | <24 hours | >24 hours | |||
High risk(1.3 days±0.5) | n=61 | n=60 | |||
Mean Haemoglobin (g/L) | 80.6±5.8 | 90.0±5.6 | 0.02 | ||
Transfusion | 50 (82.0%) | 38 (63.3%) | 1.29 (1.03–1.62) | 0.02 | |
Rebleeding | 17 (27.9%) | 13 (21.7%) | 1.29 (0.69–2.41) | 0.43 | |
Repeat Intervention* | 17 (27.9%) | 12 (20.0%) | 1.39 (0.73–2.66) | 0.31 | |
30 Day Mortality | 16 (26.2%) | 16 (26.7%) | 0.98 (0.54–1.78) | 0.96 | |
Low risk(1.5 days±0.3) | n=26 | n=63 | |||
Mean Hb (g/L) | 97.6±9.5 | 110.8±7.1 | 0.04 | ||
Transfusion | 14 (53.8%) | 16 (25.4%) | 2.12 (1.22–3.69) | 0.01 | |
Rebleeding | 2 (7.7%) | 6 (9.5%) | 0.81 (0.17–3.74) | 0.57 | |
Repeat Intervention* | 3 (11.5%) | 6 (9.5%) | 1.21 (0.33–4.48) | 0.52 | |
30 Day Mortality | 1 (3.8%) | 2 (3.2%) | 1.21 (0.12–12.19) | 0.65 |
*Repeat endoscopy/radiological intervention/surgery